Efficacy, Tolerability, and Comfort of 0.3% Hypromellose Eyedrops in Patients Undergoing LASIK Surgery
Clinical trial NCT00909324 · COMPLETED
Trial details
- NCT number
- NCT00909324
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-01
- Primary completion
- 2010-01-01
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.